These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 10432082)

  • 1. Spectrum of mammographically detected breast cancers.
    Sener SF; Winchester DJ; Winchester DP; Kurek R; Motykie G; Martz CH; Rabbitt S
    Am Surg; 1999 Aug; 65(8):731-5; discussion 735-6. PubMed ID: 10432082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between mammographic screening intervals and size and histology of ductal carcinoma in situ.
    Carlson KL; Helvie MA; Roubidoux MA; Kleer CG; Oberman HA; Wilson TE; Pollak EW; Rochester AB
    AJR Am J Roentgenol; 1999 Feb; 172(2):313-7. PubMed ID: 9930774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral breast cancer: early detection with mammography.
    Roubidoux MA; Helvie MA; Lai NE; Paramagul C
    Radiology; 1995 Aug; 196(2):427-31. PubMed ID: 7617856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening ultrasonography revealed 15% of mammographically occult breast cancers.
    Uchida K; Yamashita A; Kawase K; Kamiya K
    Breast Cancer; 2008; 15(2):165-8. PubMed ID: 18224382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of mammographic screening in the elderly.
    Faulk RM; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    Radiology; 1995 Jan; 194(1):193-7. PubMed ID: 7997552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early results of breast cancer screening research].
    Nowicki A; Stogowska I
    Ginekol Pol; 2007 Jun; 78(6):464-70. PubMed ID: 17899703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Method of tumor detection influences disease-free survival of women with breast carcinoma.
    Senie RT; Lesser M; Kinne DW; Rosen PP
    Cancer; 1994 Mar; 73(6):1666-72. PubMed ID: 8156494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?
    Weigel S; Hense HW; Heidrich J; Berkemeyer S; Heindel W; Heidinger O
    Radiology; 2016 Mar; 278(3):707-13. PubMed ID: 26505802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive breast cancer: mammographic measurement.
    Flanagan FL; McDermott MB; Barton PT; Pilgram TK; Dehdashti F; Wick MR; Monsees BS
    Radiology; 1996 Jun; 199(3):819-23. PubMed ID: 8638011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ductal carcinoma in situ of the breast].
    Barth A; Köchli OR; Brenner RJ; Giuliano E; Castiglione M
    Schweiz Med Wochenschr; 1995 Jan; 125(4):103-12. PubMed ID: 7878398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation.
    Evans AJ; Pinder S; Ellis IO; Sibbering M; Elston CW; Poller DN; Wilson R
    Radiology; 1994 Apr; 191(1):237-40. PubMed ID: 8134579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of probably benign lesions in non-screening breast diagnostics.
    Kapsimalakou S; Waldmann A; Katalinic A; Grande-Nagel I; Fischer D; Barkhausen J; Vogt FM
    Arch Gynecol Obstet; 2014 Sep; 290(3):543-51. PubMed ID: 24722993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer?
    Jatoi I; Baum M
    Surgery; 1995 Jul; 118(1):118-20. PubMed ID: 7604373
    [No Abstract]   [Full Text] [Related]  

  • 18. Local tumor recurrence following breast-conservation therapy: correlation of histopathologic findings with detection method and mammographic findings.
    Giess CS; Keating DM; Osborne MP; Rosenblatt R
    Radiology; 1999 Sep; 212(3):829-35. PubMed ID: 10478253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of additional imaging increased specificity and decreased sensitivity in screening mammography.
    Geller BM; Vacek PM; Skelly J; Harvey SC
    J Clin Epidemiol; 2005 Sep; 58(9):942-50. PubMed ID: 16085198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.